Transcripta Bio Announces $24 Million Funding

· vcnewsdaily.com

PALO ALTO, CA, Transcripta Bio, an AI-powered drug discovery company focused on neurological and neuromuscular diseases, announced it has raised $24 million since its Series A.

Transcripta Bio Announces $24 Million Funding Back to Home

PALO ALTO, CA, Transcripta Bio, an AI-powered drug discovery company focused on neurological and neu...


Read on WOBR AI → · More AI market news · StrategyVerse · Quant Research · WOBR.AI